Works matching IS 00099104 AND DT 2021 AND VI 203 AND IP 2

Results: 17

Late diagnosis and advances in genetics of chronic granulomatous disease.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 244, doi. 10.1111/cei.13554
By:
- Di Matteo, G.;
- Finocchi, A.
Publication type:
Article
Does the BCG vaccine have different effects on strains of tuberculosis?
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 281, doi. 10.1111/cei.13549
By:
- Kousha, A.;
- Farajnia, S.;
- Ansarin, K.;
- Khalili, M.;
- Shariat, M.;
- Sahebi, L.
Publication type:
Article
Diagnostic characterization of respiratory allergies by means of a multiplex immunoassay.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 183, doi. 10.1111/cei.13548
By:
- Millen, J. L. M.;
- Willems, I.;
- Slingers, G.;
- Raes, M.;
- Koppen, G.;
- Langie, S. A. S.
Publication type:
Article
Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi‐drug‐resistant tuberculosis.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 267, doi. 10.1111/cei.13544
By:
- Imperiale, B. R.;
- García, A.;
- Minotti, A.;
- González Montaner, P.;
- Moracho, L.;
- Morcillo, N. S.;
- Palmero, D. J.;
- Sasiain, M. del Carmen;
- Barrera, S.
Publication type:
Article
The role of interleukin‐18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome – a systematic review.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 174, doi. 10.1111/cei.13543
By:
- Krei, J. M.;
- Møller, H. J.;
- Larsen, J. B.
Publication type:
Article
Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 160, doi. 10.1111/cei.13542
By:
- Pouw, J. N.;
- Leijten, E. F. A.;
- Laar, J. M.;
- Boes, M.
Publication type:
Article
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 304, doi. 10.1111/cei.13541
By:
- Valestrand, L.;
- Berntsen, N. L.;
- Zheng, F.;
- Schrumpf, E.;
- Hansen, S. H.;
- Karlsen, T. H.;
- Blumberg, R. S.;
- Hov, J. R.;
- Jiang, X.;
- Melum, E.
Publication type:
Article
Kinetic studies of galectin‐10 release from eosinophils exposed to proliferating T cells.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 230, doi. 10.1111/cei.13540
By:
- Lingblom, C.;
- Andersson, K.;
- Wennerås, C.
Publication type:
Article
CD11c<sup>+</sup> dendritic cells mediate antigen‐specific suppression in extracorporeal photopheresis.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 329, doi. 10.1111/cei.13539
By:
- Hackstein, H.;
- Kalina, A.;
- Dorn, B.;
- Keil, I. S.;
- Baal, N.;
- Michel, G.;
- Brendel, C.;
- Neubauer, A.;
- Jakob, T.;
- Bein, G.
Publication type:
Article
Interleukin‐35 has a tumor‐promoting role in hepatocellular carcinoma.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 219, doi. 10.1111/cei.13535
By:
- Liu, X.;
- Ren, H.;
- Guo, H.;
- Wang, W.;
- Zhao, N.
Publication type:
Article
Identification of peripheral CD154<sup>+</sup> T cells and HLA‐DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 315, doi. 10.1111/cei.13533
By:
- Boix, F.;
- Legaz, I.;
- Minhas, A.;
- Alfaro, R.;
- Jiménez–Coll, V.;
- Mrowiec, A.;
- Martínez–Banaclocha, H.;
- Galián, J. A.;
- Botella, C.;
- Moya–Quiles, M. R.;
- Sanchez–Bueno, F.;
- Robles, R.;
- Peña–Moral, J.;
- Ramirez, P.;
- Pons, J. A.;
- Minguela, A.;
- Muro, M.
Publication type:
Article
Relapse rate and renal prognosis in ANCA‐associated vasculitis according to long‐term ANCA patterns.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 209, doi. 10.1111/cei.13530
By:
- Oristrell, J.;
- Loureiro‐Amigo, J.;
- Solans, R.;
- Valenzuela, M. P.;
- Monsálvez, V.;
- Segarra, A.;
- Amengual, M. J.;
- Marín, A.;
- Feijoo, C.;
- Tolosa, C.
Publication type:
Article
Leukocyte immunoglobulin‐like receptor A3 is increased in IBD patients and functions as an anti‐inflammatory modulator.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 286, doi. 10.1111/cei.13529
By:
- Lan, X.;
- Liu, F.;
- Ma, J.;
- Chang, Y.;
- Xiang, L.;
- Shen, X.;
- Zhou, F.;
- Zhao, Q.
Publication type:
Article
Increased expression of CXCL2 in ACPA‐positive rheumatoid arthritis and its role in osteoclastogenesis.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 194, doi. 10.1111/cei.13527
By:
- Wang, X.;
- Sun, L.;
- He, N.;
- An, Z.;
- Yu, R.;
- Li, C.;
- Li, Y.;
- Liu, X.;
- Fang, X.;
- Zhao, J.
Publication type:
Article
Type I interferon regulates cytokine‐delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 151, doi. 10.1111/cei.13525
By:
- Glennon‐Alty, L.;
- Moots, R. J.;
- Edwards, S. W.;
- Wright, H. L.
Publication type:
Article
Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants – identification of 11 novel mutations in CYBB.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 247, doi. 10.1111/cei.13520
By:
- Mollin, M.;
- Beaumel, S.;
- Vigne, B.;
- Brault, J.;
- Roux‐Buisson, N.;
- Rendu, J.;
- Barlogis, V.;
- Catho, G.;
- Dumeril, C.;
- Fouyssac, F.;
- Monnier, D.;
- Gandemer, V.;
- Revest, M.;
- Brion, J.‐P.;
- Bost‐Bru, C.;
- Jeziorski, E.;
- Eitenschenck, L.;
- Jarrasse, C.;
- Drillon Haus, S.;
- Houachée‐Chardin, M.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 2, p. 1, doi. 10.1111/cei.13457
Publication type:
Article